IBDEI0RJ ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,12396,1,3,0)
;;=3^HIV Counseling
;;^UTILITY(U,$J,358.3,12396,1,4,0)
;;=4^Z71.7
;;^UTILITY(U,$J,358.3,12396,2)
;;=^5063251
;;^UTILITY(U,$J,358.3,12397,0)
;;=Z76.89^^49^599^5
;;^UTILITY(U,$J,358.3,12397,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12397,1,3,0)
;;=3^Persons Encountering Health Services for Oth Circumstances
;;^UTILITY(U,$J,358.3,12397,1,4,0)
;;=4^Z76.89
;;^UTILITY(U,$J,358.3,12397,2)
;;=^5063304
;;^UTILITY(U,$J,358.3,12398,0)
;;=Z01.812^^49^599^3
;;^UTILITY(U,$J,358.3,12398,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12398,1,3,0)
;;=3^Lab Result Counseling
;;^UTILITY(U,$J,358.3,12398,1,4,0)
;;=4^Z01.812
;;^UTILITY(U,$J,358.3,12398,2)
;;=^5062627
;;^UTILITY(U,$J,358.3,12399,0)
;;=Z11.7^^49^599^6
;;^UTILITY(U,$J,358.3,12399,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12399,1,3,0)
;;=3^Testing for Latent Tuberculosis Infection
;;^UTILITY(U,$J,358.3,12399,1,4,0)
;;=4^Z11.7
;;^UTILITY(U,$J,358.3,12399,2)
;;=^5158320
;;^UTILITY(U,$J,358.3,12400,0)
;;=Z22.7^^49^599^4
;;^UTILITY(U,$J,358.3,12400,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12400,1,3,0)
;;=3^Latent Tuberculosis
;;^UTILITY(U,$J,358.3,12400,1,4,0)
;;=4^Z22.7
;;^UTILITY(U,$J,358.3,12400,2)
;;=^5158321
;;^UTILITY(U,$J,358.3,12401,0)
;;=E03.9^^49^600^29
;;^UTILITY(U,$J,358.3,12401,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12401,1,3,0)
;;=3^Hypothroidism,Unspec
;;^UTILITY(U,$J,358.3,12401,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,12401,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,12402,0)
;;=E11.9^^49^600^23
;;^UTILITY(U,$J,358.3,12402,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12402,1,3,0)
;;=3^DM Type 2 w/o Complications
;;^UTILITY(U,$J,358.3,12402,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,12402,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,12403,0)
;;=E10.9^^49^600^7
;;^UTILITY(U,$J,358.3,12403,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12403,1,3,0)
;;=3^DM Type 1 w/o Complications
;;^UTILITY(U,$J,358.3,12403,1,4,0)
;;=4^E10.9
;;^UTILITY(U,$J,358.3,12403,2)
;;=^5002626
;;^UTILITY(U,$J,358.3,12404,0)
;;=E11.65^^49^600^16
;;^UTILITY(U,$J,358.3,12404,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12404,1,3,0)
;;=3^DM Type 2 w/ Hyperglycemia
;;^UTILITY(U,$J,358.3,12404,1,4,0)
;;=4^E11.65
;;^UTILITY(U,$J,358.3,12404,2)
;;=^5002663
;;^UTILITY(U,$J,358.3,12405,0)
;;=E53.8^^49^600^34
;;^UTILITY(U,$J,358.3,12405,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12405,1,3,0)
;;=3^Vitamin B Deficiency NEC
;;^UTILITY(U,$J,358.3,12405,1,4,0)
;;=4^E53.8
;;^UTILITY(U,$J,358.3,12405,2)
;;=^5002797
;;^UTILITY(U,$J,358.3,12406,0)
;;=E78.5^^49^600^27
;;^UTILITY(U,$J,358.3,12406,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12406,1,3,0)
;;=3^Hyperlipidemia,Unspec
;;^UTILITY(U,$J,358.3,12406,1,4,0)
;;=4^E78.5
;;^UTILITY(U,$J,358.3,12406,2)
;;=^5002969
;;^UTILITY(U,$J,358.3,12407,0)
;;=E66.01^^49^600^31
;;^UTILITY(U,$J,358.3,12407,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12407,1,3,0)
;;=3^Morbid Obesity
;;^UTILITY(U,$J,358.3,12407,1,4,0)
;;=4^E66.01
;;^UTILITY(U,$J,358.3,12407,2)
;;=^5002826
;;^UTILITY(U,$J,358.3,12408,0)
;;=D64.9^^49^600^6
;;^UTILITY(U,$J,358.3,12408,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,12408,1,3,0)
;;=3^Anemia,Unspec
;;^UTILITY(U,$J,358.3,12408,1,4,0)
;;=4^D64.9
;;^UTILITY(U,$J,358.3,12408,2)
;;=^5002351
;;^UTILITY(U,$J,358.3,12409,0)
;;=D68.318^^49^600^25
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0RJ 3796 printed Apr 09, 2024@20:54:25 Page 2
IBDEI0RJ ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,12396,1,3,0)
+2 ;;=3^HIV Counseling
+3 ;;^UTILITY(U,$J,358.3,12396,1,4,0)
+4 ;;=4^Z71.7
+5 ;;^UTILITY(U,$J,358.3,12396,2)
+6 ;;=^5063251
+7 ;;^UTILITY(U,$J,358.3,12397,0)
+8 ;;=Z76.89^^49^599^5
+9 ;;^UTILITY(U,$J,358.3,12397,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,12397,1,3,0)
+12 ;;=3^Persons Encountering Health Services for Oth Circumstances
+13 ;;^UTILITY(U,$J,358.3,12397,1,4,0)
+14 ;;=4^Z76.89
+15 ;;^UTILITY(U,$J,358.3,12397,2)
+16 ;;=^5063304
+17 ;;^UTILITY(U,$J,358.3,12398,0)
+18 ;;=Z01.812^^49^599^3
+19 ;;^UTILITY(U,$J,358.3,12398,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,12398,1,3,0)
+22 ;;=3^Lab Result Counseling
+23 ;;^UTILITY(U,$J,358.3,12398,1,4,0)
+24 ;;=4^Z01.812
+25 ;;^UTILITY(U,$J,358.3,12398,2)
+26 ;;=^5062627
+27 ;;^UTILITY(U,$J,358.3,12399,0)
+28 ;;=Z11.7^^49^599^6
+29 ;;^UTILITY(U,$J,358.3,12399,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,12399,1,3,0)
+32 ;;=3^Testing for Latent Tuberculosis Infection
+33 ;;^UTILITY(U,$J,358.3,12399,1,4,0)
+34 ;;=4^Z11.7
+35 ;;^UTILITY(U,$J,358.3,12399,2)
+36 ;;=^5158320
+37 ;;^UTILITY(U,$J,358.3,12400,0)
+38 ;;=Z22.7^^49^599^4
+39 ;;^UTILITY(U,$J,358.3,12400,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,12400,1,3,0)
+42 ;;=3^Latent Tuberculosis
+43 ;;^UTILITY(U,$J,358.3,12400,1,4,0)
+44 ;;=4^Z22.7
+45 ;;^UTILITY(U,$J,358.3,12400,2)
+46 ;;=^5158321
+47 ;;^UTILITY(U,$J,358.3,12401,0)
+48 ;;=E03.9^^49^600^29
+49 ;;^UTILITY(U,$J,358.3,12401,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,12401,1,3,0)
+52 ;;=3^Hypothroidism,Unspec
+53 ;;^UTILITY(U,$J,358.3,12401,1,4,0)
+54 ;;=4^E03.9
+55 ;;^UTILITY(U,$J,358.3,12401,2)
+56 ;;=^5002476
+57 ;;^UTILITY(U,$J,358.3,12402,0)
+58 ;;=E11.9^^49^600^23
+59 ;;^UTILITY(U,$J,358.3,12402,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,12402,1,3,0)
+62 ;;=3^DM Type 2 w/o Complications
+63 ;;^UTILITY(U,$J,358.3,12402,1,4,0)
+64 ;;=4^E11.9
+65 ;;^UTILITY(U,$J,358.3,12402,2)
+66 ;;=^5002666
+67 ;;^UTILITY(U,$J,358.3,12403,0)
+68 ;;=E10.9^^49^600^7
+69 ;;^UTILITY(U,$J,358.3,12403,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,12403,1,3,0)
+72 ;;=3^DM Type 1 w/o Complications
+73 ;;^UTILITY(U,$J,358.3,12403,1,4,0)
+74 ;;=4^E10.9
+75 ;;^UTILITY(U,$J,358.3,12403,2)
+76 ;;=^5002626
+77 ;;^UTILITY(U,$J,358.3,12404,0)
+78 ;;=E11.65^^49^600^16
+79 ;;^UTILITY(U,$J,358.3,12404,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,12404,1,3,0)
+82 ;;=3^DM Type 2 w/ Hyperglycemia
+83 ;;^UTILITY(U,$J,358.3,12404,1,4,0)
+84 ;;=4^E11.65
+85 ;;^UTILITY(U,$J,358.3,12404,2)
+86 ;;=^5002663
+87 ;;^UTILITY(U,$J,358.3,12405,0)
+88 ;;=E53.8^^49^600^34
+89 ;;^UTILITY(U,$J,358.3,12405,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,12405,1,3,0)
+92 ;;=3^Vitamin B Deficiency NEC
+93 ;;^UTILITY(U,$J,358.3,12405,1,4,0)
+94 ;;=4^E53.8
+95 ;;^UTILITY(U,$J,358.3,12405,2)
+96 ;;=^5002797
+97 ;;^UTILITY(U,$J,358.3,12406,0)
+98 ;;=E78.5^^49^600^27
+99 ;;^UTILITY(U,$J,358.3,12406,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,12406,1,3,0)
+102 ;;=3^Hyperlipidemia,Unspec
+103 ;;^UTILITY(U,$J,358.3,12406,1,4,0)
+104 ;;=4^E78.5
+105 ;;^UTILITY(U,$J,358.3,12406,2)
+106 ;;=^5002969
+107 ;;^UTILITY(U,$J,358.3,12407,0)
+108 ;;=E66.01^^49^600^31
+109 ;;^UTILITY(U,$J,358.3,12407,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,12407,1,3,0)
+112 ;;=3^Morbid Obesity
+113 ;;^UTILITY(U,$J,358.3,12407,1,4,0)
+114 ;;=4^E66.01
+115 ;;^UTILITY(U,$J,358.3,12407,2)
+116 ;;=^5002826
+117 ;;^UTILITY(U,$J,358.3,12408,0)
+118 ;;=D64.9^^49^600^6
+119 ;;^UTILITY(U,$J,358.3,12408,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,12408,1,3,0)
+122 ;;=3^Anemia,Unspec
+123 ;;^UTILITY(U,$J,358.3,12408,1,4,0)
+124 ;;=4^D64.9
+125 ;;^UTILITY(U,$J,358.3,12408,2)
+126 ;;=^5002351
+127 ;;^UTILITY(U,$J,358.3,12409,0)
+128 ;;=D68.318^^49^600^25
